USPTO serial 79447038
Reviewed by CopyMark Law Group
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ronni S. Jillions
Ronni S. Jillions FisherBroyles, LLP9705 Hill Streetc/o Roger L. BrowdyKensington, MD 20895-3134| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded computer software for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable computer software for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable application software for the detection and quantification of biomarkers and analytes; recorded computer software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable computer software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable application software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins | ACTIVE | — |
| 010 | Medical diagnostic apparatus for testing for viruses; medical diagnostic testing instruments for use in immunoassay procedures to test for cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus being digital rapid test readers for detecting and quantifying biomarkers and analytes related to cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins, incorporating software for the monitoring and management of the previously mentioned conditions | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 7, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 7, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 21, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 21, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 4, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 2, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |